🇺🇸 FDA
Patent

US 6475741

Neutrophil chemotactic factor cloned cDNA and monoclonal antibodies thereto

expired A61KA61K38/00A61P

Quick answer

US patent 6475741 (Neutrophil chemotactic factor cloned cDNA and monoclonal antibodies thereto) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Nov 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K38/00, A61P, A61P29/00